David A. Siegel Novavax Inc Transaction History

Two Sigma Advisers, LP

$46.1 Billion
Q2 2025

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Novavax Inc stock. As of the latest transaction made, Two Sigma Advisers, LP holds 21,700 shares of NVAX stock, worth $184,016. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,700

Previous 614,000 96.47%

Holding current value

$184,016

Previous $3.94 Million 96.54%

% of portfolio

0.0%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$5.43 - $7.74 $3.22 Million - $4.58 Million	-592,300 Reduced 96.47%	21,700 $136,000
Q1 2025 May 15, 2025	SELL	$6.41 - $10.82 $1.06 Million - $1.79 Million	-165,700 Reduced 21.25%	614,000 $3.94 Million
Q4 2024 Feb 14, 2025	SELL	$7.22 - $14.68 $8.81 Million - $17.9 Million	-1,219,700 Reduced 61.0%	779,700 $6.27 Million
Q3 2024 Nov 14, 2024	BUY	$10.71 - $17.11 $7.04 Million - $11.2 Million	656,900 Added 48.93%	1,999,400 $25.3 Million
Q2 2024 Aug 14, 2024	BUY	$3.89 - $20.97 $5.22 Million - $28.2 Million	1,342,500 New	1,342,500 $17 Million
Q2 2023 Aug 14, 2023	SELL	$6.67 - $9.52 $91,379 - $130,424	-13,700 Reduced 36.15%	24,200 $179,000
Q1 2023 May 15, 2023	BUY	$5.76 - $12.48 $137,664 - $298,272	23,900 Added 170.71%	37,900 $262,000
Q4 2022 Feb 14, 2023	BUY	$8.86 - $25.04 $124,039 - $350,560	14,000 New	14,000 $143,000
Q2 2022 Aug 15, 2022	SELL	$36.28 - $75.29 $101,584 - $210,812	-2,800 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$69.73 - $142.9 $97,622 - $200,060	1,400 Added 100.0%	2,800 $206,000
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $538,240 - $871,880	-4,000 Reduced 74.07%	1,400 $200,000
Q3 2021 Nov 15, 2021	BUY	$177.8 - $270.58 $960,120 - $1.46 Million	5,400 New	5,400 $1.12 Million
Q1 2021 May 17, 2021	SELL	$112.98 - $319.93 $2.56 Million - $7.26 Million	-22,700 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$78.74 - $139.5 $8.52 Million - $15.1 Million	-108,200 Reduced 82.66%	22,700 $2.53 Million
Q3 2020 Nov 16, 2020	BUY	$79.44 - $178.51 $10.4 Million - $23.4 Million	130,900 New	130,900 $14.2 Million
Q4 2019 Feb 14, 2020	SELL	$3.69 - $5.22 $286,200 - $404,868	-77,561 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$4.02 - $7.84 $433,094 - $844,642	-107,735 Reduced 58.14%	77,561 $389,000
Q2 2019 Aug 14, 2019	BUY	$4.93 - $12.2 $913,509 - $2.26 Million	185,296 New	185,296 $1.09 Million

Others Institutions Holding NVAX

# of Institutions

315

Shares Held

94.7M

Call Options Held

6.11M

Put Options Held

10.5M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $663M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account